Archford Capital Strategies, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 150 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Archford Capital Strategies, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2016$20,000
-23.1%
4,5000.0%0.01%
-42.9%
Q2 2016$26,000
-99.4%
4,500
+15971.4%
0.01%
+600.0%
Q1 2016$4,500,000
+10614.3%
28
-99.4%
0.00%
-89.5%
Q4 2015$42,000
+68.0%
4,5000.0%0.02%0.0%
Q3 2015$25,000
-50.0%
4,5000.0%0.02%
-47.2%
Q2 2015$50,000
-99.9%
4,5000.0%0.04%
-26.5%
Q1 2015$70,560,000
+103664.7%
4,5000.0%0.05%
-2.0%
Q4 2014$68,000
+38.8%
4,5000.0%0.05%
+28.2%
Q3 2014$49,000
-99.9%
4,5000.0%0.04%
-26.4%
Q2 2014$68,715,000
-15.5%
4,5000.0%0.05%
-22.1%
Q1 2014$81,360,0004,5000.07%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders